VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 514 filers reported holding VANECK VECTORS ETF TR in Q1 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,910,000 | +33.4% | 10,000 | -96.4% | 3.82% | +107.9% |
Q2 2023 | $20,173,700 | +131.0% | 274,000 | +1.5% | 1.84% | +30.8% |
Q1 2023 | $8,734,500 | +60.4% | 270,000 | +42.1% | 1.40% | +13.0% |
Q4 2022 | $5,445,400 | -46.5% | 190,000 | -26.9% | 1.24% | -29.7% |
Q3 2020 | $10,182,000 | -44.5% | 260,000 | -48.0% | 1.77% | -70.5% |
Q2 2020 | $18,340,000 | +368.2% | 500,000 | +194.1% | 5.99% | +51.8% |
Q1 2020 | $3,917,000 | -27.7% | 170,000 | -8.1% | 3.95% | +21.2% |
Q4 2019 | $5,417,000 | – | 185,000 | – | 3.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |